Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

Christine Årdal, Enrico Baraldi, Ursula Theuretzbacher, Kevin Outterson, Jens Plahte, Francesco Ciabuschi, John-Arne Røttingen

ABSTRACT

Background: Antibiotic innovation has dwindled to dangerously low levels in the past 30 years. Since resistance continues to evolve, this innovation deficit can have perilous consequences on patients. A number of new incentives have been suggested to stimulate greater antibacterial drug innovation. To design effective solutions, a greater understanding is needed of actual antibiotic discovery and development costs and timelines. Small and medium-sized enterprises (SMEs) undertake most discovery and early phase development for antibiotics and other drugs. This paper attempts to gather a better understanding of SMEs' targets, costs, and durations related to discovery and early phase development of antibacterial therapies. Methods: DRIVE-AB, a project focused on developing new economic incentives to stimulate antibacterial innovation, held a European stakeholder meeting in February 2015. All SMEs invited to this meeting (n = 44) were subsequently sent a survey to gather more data regarding their areas of activity, completed and expected development costs and timelines, and business models. Results: Twenty-five companies responded to the survey. Respondents were primarily small companies each focusing on developing 1 to 3 new antibiotics, focused on pathogens of public health importance. Most have not yet completed any clinical trials. They have reported ranges of discovery and development out-of-pocket costs that appear to be less expensive than other studies of general pharmaceutical research and development (R&D) costs. The duration ranges reported for completing each phase of R&D are highly variable when compared to previously published general pharmaceutical innovation average durations. However, our sample population is small and may not be fully representative of all relevant antibiotic SMEs. Conclusions: The data collected by this study provide important insights and estimates about R&D in European SMEs focusing on antibiotics, which can be combined with other data to design incentives to stimulate antibacterial innovation. The variation implies that costs and durations are difficult to generalize due to the unique characteristics of each antibiotic project and depend on individual business strategies and circumstances. More... »

PAGES

8

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s40545-018-0135-0

DOI

http://dx.doi.org/10.1186/s40545-018-0135-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1103128502

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29632669


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1503", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Business and Management", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/15", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Commerce, Management, Tourism and Services", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Norwegian Institute of Public Health", 
          "id": "https://www.grid.ac/institutes/grid.418193.6", 
          "name": [
            "Norwegian Institute of Public Health, Postboks 4404 Nydalen, 0403, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "\u00c5rdal", 
        "givenName": "Christine", 
        "id": "sg:person.0657474211.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657474211.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Uppsala University", 
          "id": "https://www.grid.ac/institutes/grid.8993.b", 
          "name": [
            "Uppsala University, Box 513, 751 20, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baraldi", 
        "givenName": "Enrico", 
        "id": "sg:person.014147724211.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014147724211.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Center for Anti-Infective Agents, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Theuretzbacher", 
        "givenName": "Ursula", 
        "id": "sg:person.0610347730.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610347730.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Boston University", 
          "id": "https://www.grid.ac/institutes/grid.189504.1", 
          "name": [
            "Boston University, 765 Commonwealth Avenue, 02215, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Outterson", 
        "givenName": "Kevin", 
        "id": "sg:person.0635205222.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635205222.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Norwegian Institute of Public Health", 
          "id": "https://www.grid.ac/institutes/grid.418193.6", 
          "name": [
            "Norwegian Institute of Public Health, Postboks 4404 Nydalen, 0403, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Plahte", 
        "givenName": "Jens", 
        "id": "sg:person.01271753243.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271753243.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Uppsala University", 
          "id": "https://www.grid.ac/institutes/grid.8993.b", 
          "name": [
            "Uppsala University, Box 513, 751 20, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ciabuschi", 
        "givenName": "Francesco", 
        "id": "sg:person.011055342653.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011055342653.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Norwegian Institute of Public Health, University of Oslo, Postboks 4404 Nydalen, 0403, Boks 1072 Blindern, 0316, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "R\u00f8ttingen", 
        "givenName": "John-Arne", 
        "id": "sg:person.01207073626.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207073626.16"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0140-6736(15)00474-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003178984"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/cmr.00030-10", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006875263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd.2016.229", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009460305", 
          "https://doi.org/10.1038/nrd.2016.229"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1057/biosoc.2010.40", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010750210", 
          "https://doi.org/10.1057/biosoc.2010.40"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd3078", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016256401", 
          "https://doi.org/10.1038/nrd3078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd3078", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016256401", 
          "https://doi.org/10.1038/nrd3078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1473-3099(13)70318-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018650635"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jac/dkv020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023906984"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1473-3099(15)00500-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026058493"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ja.2015.98", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027730298", 
          "https://doi.org/10.1038/ja.2015.98"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1254163", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027827915"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.drudis.2014.07.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031649204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jhealeco.2016.01.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042169659"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1377/hlthaff.2014.1003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048299986"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/m16-0291", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073743011"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "Background: Antibiotic innovation has dwindled to dangerously low levels in the past 30\u00a0years. Since resistance continues to evolve, this innovation deficit can have perilous consequences on patients. A number of new incentives have been suggested to stimulate greater antibacterial drug innovation. To design effective solutions, a greater understanding is needed of actual antibiotic discovery and development costs and timelines. Small and medium-sized enterprises (SMEs) undertake most discovery and early phase development for antibiotics and other drugs. This paper attempts to gather a better understanding of SMEs' targets, costs, and durations related to discovery and early phase development of antibacterial therapies.\nMethods: DRIVE-AB, a project focused on developing new economic incentives to stimulate antibacterial innovation, held a European stakeholder meeting in February 2015. All SMEs invited to this meeting (n\u2009=\u200944) were subsequently sent a survey to gather more data regarding their areas of activity, completed and expected development costs and timelines, and business models.\nResults: Twenty-five companies responded to the survey. Respondents were primarily small companies each focusing on developing 1 to 3 new antibiotics, focused on pathogens of public health importance. Most have not yet completed any clinical trials. They have reported ranges of discovery and development out-of-pocket costs that appear to be less expensive than other studies of general pharmaceutical research and development (R&D) costs. The duration ranges reported for completing each phase of R&D are highly variable when compared to previously published general pharmaceutical innovation average durations. However, our sample population is small and may not be fully representative of all relevant antibiotic SMEs.\nConclusions: The data collected by this study provide important insights and estimates about R&D in European SMEs focusing on antibiotics, which can be combined with other data to design incentives to stimulate antibacterial innovation. The variation implies that costs and durations are difficult to generalize due to the unique characteristics of each antibiotic project and depend on individual business strategies and circumstances.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s40545-018-0135-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.4639944", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1045870", 
        "issn": [
          "2052-3211"
        ], 
        "name": "Journal of Pharmaceutical Policy and Practice", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "name": "Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations", 
    "pagination": "8", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "fdbcbbfb0b39f58f90ae137453f920fcbed78e2bc4512a0703022a45f9387828"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29632669"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101627192"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s40545-018-0135-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1103128502"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s40545-018-0135-0", 
      "https://app.dimensions.ai/details/publication/pub.1103128502"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130808_00000005.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs40545-018-0135-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40545-018-0135-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40545-018-0135-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40545-018-0135-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40545-018-0135-0'


 

This table displays all metadata directly associated to this object as RDF triples.

168 TRIPLES      21 PREDICATES      43 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s40545-018-0135-0 schema:about anzsrc-for:15
2 anzsrc-for:1503
3 schema:author N86bc1f1433ed44d19da8054f2c6deb64
4 schema:citation sg:pub.10.1038/ja.2015.98
5 sg:pub.10.1038/nrd.2016.229
6 sg:pub.10.1038/nrd3078
7 sg:pub.10.1057/biosoc.2010.40
8 https://doi.org/10.1016/j.drudis.2014.07.005
9 https://doi.org/10.1016/j.jhealeco.2016.01.012
10 https://doi.org/10.1016/s0140-6736(15)00474-2
11 https://doi.org/10.1016/s1473-3099(13)70318-9
12 https://doi.org/10.1016/s1473-3099(15)00500-9
13 https://doi.org/10.1093/jac/dkv020
14 https://doi.org/10.1126/science.1254163
15 https://doi.org/10.1128/cmr.00030-10
16 https://doi.org/10.1377/hlthaff.2014.1003
17 https://doi.org/10.7326/m16-0291
18 schema:datePublished 2018-12
19 schema:datePublishedReg 2018-12-01
20 schema:description Background: Antibiotic innovation has dwindled to dangerously low levels in the past 30 years. Since resistance continues to evolve, this innovation deficit can have perilous consequences on patients. A number of new incentives have been suggested to stimulate greater antibacterial drug innovation. To design effective solutions, a greater understanding is needed of actual antibiotic discovery and development costs and timelines. Small and medium-sized enterprises (SMEs) undertake most discovery and early phase development for antibiotics and other drugs. This paper attempts to gather a better understanding of SMEs' targets, costs, and durations related to discovery and early phase development of antibacterial therapies. Methods: DRIVE-AB, a project focused on developing new economic incentives to stimulate antibacterial innovation, held a European stakeholder meeting in February 2015. All SMEs invited to this meeting (n = 44) were subsequently sent a survey to gather more data regarding their areas of activity, completed and expected development costs and timelines, and business models. Results: Twenty-five companies responded to the survey. Respondents were primarily small companies each focusing on developing 1 to 3 new antibiotics, focused on pathogens of public health importance. Most have not yet completed any clinical trials. They have reported ranges of discovery and development out-of-pocket costs that appear to be less expensive than other studies of general pharmaceutical research and development (R&D) costs. The duration ranges reported for completing each phase of R&D are highly variable when compared to previously published general pharmaceutical innovation average durations. However, our sample population is small and may not be fully representative of all relevant antibiotic SMEs. Conclusions: The data collected by this study provide important insights and estimates about R&D in European SMEs focusing on antibiotics, which can be combined with other data to design incentives to stimulate antibacterial innovation. The variation implies that costs and durations are difficult to generalize due to the unique characteristics of each antibiotic project and depend on individual business strategies and circumstances.
21 schema:genre research_article
22 schema:inLanguage en
23 schema:isAccessibleForFree true
24 schema:isPartOf N3c2864c3d7b445d6aa39073db4faac36
25 N99c9a49241ca471c8b05dcf2d1b0bbbc
26 sg:journal.1045870
27 schema:name Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations
28 schema:pagination 8
29 schema:productId N4191883f9b9843779d72fe29261421b0
30 N95bd265feeb14352b6ae5b9912fcabae
31 Na9d36c15a9764bf38de505067ff4026c
32 Nb783d702bd5b40ffb40f40f84ce7eeb2
33 Ne19ddb5530134556aafd1ab4e6f44d7f
34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103128502
35 https://doi.org/10.1186/s40545-018-0135-0
36 schema:sdDatePublished 2019-04-11T13:54
37 schema:sdLicense https://scigraph.springernature.com/explorer/license/
38 schema:sdPublisher Nc6f33baf5d2a4dc798ae9b98f107a59c
39 schema:url https://link.springer.com/10.1186%2Fs40545-018-0135-0
40 sgo:license sg:explorer/license/
41 sgo:sdDataset articles
42 rdf:type schema:ScholarlyArticle
43 N2a7c82992f204791a801791d33793368 rdf:first sg:person.01271753243.42
44 rdf:rest Nfc9c0b3cc43344cfbfe4cb164879cb73
45 N3352f8a04f204a29a462fc068b8190c1 rdf:first sg:person.0610347730.20
46 rdf:rest Naaf9ea003c3540b0adffdce3e47abf9f
47 N3c2864c3d7b445d6aa39073db4faac36 schema:issueNumber 1
48 rdf:type schema:PublicationIssue
49 N4191883f9b9843779d72fe29261421b0 schema:name nlm_unique_id
50 schema:value 101627192
51 rdf:type schema:PropertyValue
52 N63d9967bb0e841c1b5ad203fdbb1a2fe rdf:first sg:person.01207073626.16
53 rdf:rest rdf:nil
54 N86bc1f1433ed44d19da8054f2c6deb64 rdf:first sg:person.0657474211.42
55 rdf:rest Ndeed4117668e4d79ad06b665553e743d
56 N95bd265feeb14352b6ae5b9912fcabae schema:name readcube_id
57 schema:value fdbcbbfb0b39f58f90ae137453f920fcbed78e2bc4512a0703022a45f9387828
58 rdf:type schema:PropertyValue
59 N99c9a49241ca471c8b05dcf2d1b0bbbc schema:volumeNumber 11
60 rdf:type schema:PublicationVolume
61 Na8b609fb2c5b49679a89d5105f9dd342 schema:name Norwegian Institute of Public Health, University of Oslo, Postboks 4404 Nydalen, 0403, Boks 1072 Blindern, 0316, Oslo, Norway
62 rdf:type schema:Organization
63 Na9d36c15a9764bf38de505067ff4026c schema:name doi
64 schema:value 10.1186/s40545-018-0135-0
65 rdf:type schema:PropertyValue
66 Naaf9ea003c3540b0adffdce3e47abf9f rdf:first sg:person.0635205222.54
67 rdf:rest N2a7c82992f204791a801791d33793368
68 Nb783d702bd5b40ffb40f40f84ce7eeb2 schema:name pubmed_id
69 schema:value 29632669
70 rdf:type schema:PropertyValue
71 Nc6f33baf5d2a4dc798ae9b98f107a59c schema:name Springer Nature - SN SciGraph project
72 rdf:type schema:Organization
73 Ndeed4117668e4d79ad06b665553e743d rdf:first sg:person.014147724211.48
74 rdf:rest N3352f8a04f204a29a462fc068b8190c1
75 Ne19ddb5530134556aafd1ab4e6f44d7f schema:name dimensions_id
76 schema:value pub.1103128502
77 rdf:type schema:PropertyValue
78 Nf5067ccbb9804daa855fa765ca18a11d schema:name Center for Anti-Infective Agents, Vienna, Austria
79 rdf:type schema:Organization
80 Nfc9c0b3cc43344cfbfe4cb164879cb73 rdf:first sg:person.011055342653.42
81 rdf:rest N63d9967bb0e841c1b5ad203fdbb1a2fe
82 anzsrc-for:15 schema:inDefinedTermSet anzsrc-for:
83 schema:name Commerce, Management, Tourism and Services
84 rdf:type schema:DefinedTerm
85 anzsrc-for:1503 schema:inDefinedTermSet anzsrc-for:
86 schema:name Business and Management
87 rdf:type schema:DefinedTerm
88 sg:grant.4639944 http://pending.schema.org/fundedItem sg:pub.10.1186/s40545-018-0135-0
89 rdf:type schema:MonetaryGrant
90 sg:journal.1045870 schema:issn 2052-3211
91 schema:name Journal of Pharmaceutical Policy and Practice
92 rdf:type schema:Periodical
93 sg:person.011055342653.42 schema:affiliation https://www.grid.ac/institutes/grid.8993.b
94 schema:familyName Ciabuschi
95 schema:givenName Francesco
96 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011055342653.42
97 rdf:type schema:Person
98 sg:person.01207073626.16 schema:affiliation Na8b609fb2c5b49679a89d5105f9dd342
99 schema:familyName Røttingen
100 schema:givenName John-Arne
101 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207073626.16
102 rdf:type schema:Person
103 sg:person.01271753243.42 schema:affiliation https://www.grid.ac/institutes/grid.418193.6
104 schema:familyName Plahte
105 schema:givenName Jens
106 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271753243.42
107 rdf:type schema:Person
108 sg:person.014147724211.48 schema:affiliation https://www.grid.ac/institutes/grid.8993.b
109 schema:familyName Baraldi
110 schema:givenName Enrico
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014147724211.48
112 rdf:type schema:Person
113 sg:person.0610347730.20 schema:affiliation Nf5067ccbb9804daa855fa765ca18a11d
114 schema:familyName Theuretzbacher
115 schema:givenName Ursula
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610347730.20
117 rdf:type schema:Person
118 sg:person.0635205222.54 schema:affiliation https://www.grid.ac/institutes/grid.189504.1
119 schema:familyName Outterson
120 schema:givenName Kevin
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635205222.54
122 rdf:type schema:Person
123 sg:person.0657474211.42 schema:affiliation https://www.grid.ac/institutes/grid.418193.6
124 schema:familyName Årdal
125 schema:givenName Christine
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657474211.42
127 rdf:type schema:Person
128 sg:pub.10.1038/ja.2015.98 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027730298
129 https://doi.org/10.1038/ja.2015.98
130 rdf:type schema:CreativeWork
131 sg:pub.10.1038/nrd.2016.229 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009460305
132 https://doi.org/10.1038/nrd.2016.229
133 rdf:type schema:CreativeWork
134 sg:pub.10.1038/nrd3078 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016256401
135 https://doi.org/10.1038/nrd3078
136 rdf:type schema:CreativeWork
137 sg:pub.10.1057/biosoc.2010.40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010750210
138 https://doi.org/10.1057/biosoc.2010.40
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1016/j.drudis.2014.07.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031649204
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1016/j.jhealeco.2016.01.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042169659
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1016/s0140-6736(15)00474-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003178984
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1016/s1473-3099(13)70318-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018650635
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1016/s1473-3099(15)00500-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026058493
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1093/jac/dkv020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023906984
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1126/science.1254163 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027827915
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1128/cmr.00030-10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006875263
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1377/hlthaff.2014.1003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048299986
157 rdf:type schema:CreativeWork
158 https://doi.org/10.7326/m16-0291 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073743011
159 rdf:type schema:CreativeWork
160 https://www.grid.ac/institutes/grid.189504.1 schema:alternateName Boston University
161 schema:name Boston University, 765 Commonwealth Avenue, 02215, Boston, MA, USA
162 rdf:type schema:Organization
163 https://www.grid.ac/institutes/grid.418193.6 schema:alternateName Norwegian Institute of Public Health
164 schema:name Norwegian Institute of Public Health, Postboks 4404 Nydalen, 0403, Oslo, Norway
165 rdf:type schema:Organization
166 https://www.grid.ac/institutes/grid.8993.b schema:alternateName Uppsala University
167 schema:name Uppsala University, Box 513, 751 20, Uppsala, Sweden
168 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...